Sysmex Corporation ADR (OTCMKTS:SSMXY) Short Interest Update

Key Points

• Sysmex Corporation ADR experienced a significant rise in short interest, jumping by 145.8% from 2,400 shares to 5,900 shares in August.
• The company's most recent quarterly earnings report revealed an EPS of $0.05, falling short of the expected $0.12, with revenue also below analysts' forecasts at $717.09 million.
• Following recent assessments, Zacks Research upgraded Sysmex from a "strong sell" to a "hold" rating, reflecting a cautious outlook among analysts.

Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) was the target of a significant growth in short interest during the month of August. As of August 31st, there was short interest totaling 5,900 shares, a growth of 145.8% from the August 15th total of 2,400 shares. Approximately 0.0% of the company's shares are short sold. Based on an average daily volume of 271,900 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily volume of 271,900 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the company's shares are short sold.

Analyst Ratings Changes

Separately, Zacks Research upgraded Sysmex from a "strong sell" rating to a "hold" rating in a report on Thursday, August 14th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Sysmex has a consensus rating of "Hold".

Sysmex Trading Down 1.1%

Shares of Sysmex stock traded down $0.14 during trading hours on Thursday, hitting $12.76. The company's stock had a trading volume of 1,034,190 shares, compared to its average volume of 98,848. Sysmex has a 12 month low of $12.29 and a 12 month high of $22.00. The stock has a 50 day moving average of $14.54 and a 200 day moving average of $16.72. The company has a market capitalization of $8.03 billion, a PE ratio of 25.52 and a beta of 1.10. The company has a debt-to-equity ratio of 0.12, a current ratio of 3.37 and a quick ratio of 2.49.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.12 by ($0.07). The firm had revenue of $717.09 million for the quarter, compared to the consensus estimate of $807.27 million. Sysmex had a return on equity of 10.20% and a net margin of 9.35%. Analysts predict that Sysmex will post 0.57 earnings per share for the current year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.